Fire disrupts production at Alembic joint-venture generics plant in Algeria

Alembic reports fire disruption at Algerian JV generics plant.

A fire disrupted production last week at an Algerian-based generics plant—operated under a joint venture between Alembic Mami and local pharma Adwiya Mami—according to Indian drugmaker Alembic Pharma. 

Alembic made the announcement in a filing (PDF) with the Bombay Stock Exchange.

“The cause of (the) accident and the extend of damage is being investigated and assessed,” the company said in the filing. “Though the fixed assets and inventories are covered under insurance policies and we do not expect a major adverse impact, we (do) expect a disruption in operation (until) the plant is put back on stream.”

Launch Readiness

Optimize cross-functional collaboration and engage with key stakeholders for the successful launch of a product

Join the Launch Readiness for Medical Affairs & Communications Teams Summit to learn best practices in taking a structured approach to enhance medical affairs activities surrounding a launch and increase knowledge and communication with thought leaders.

The company said no one was injured in the fire, which was brought under control.

The joint venture that was formed in 2014 is Alembic’s first entry outside the Indian market. The plant in Constantine opened in 2015.